
Number of publications published per year by Mizuno, Masayuki. (Source : PubMed)

Distribution of publications types for Mizuno, Masayuki. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease.
J. Gastroenterol.
2009

[A novel formulation of cisplatin (CDDP)]
Gan To Kagaku Ryoho
2009;36;12
Antenatal glucocorticoid therapy increase cardiac alpha-enolase levels in fetus and neonate rats.
Life Sci.
2009;85;17-18
Is there a gender difference between ACE gene and race distance?
Appl Physiol Nutr Metab
2009;34;5
Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
J Surg Oncol
2009;100;4
Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism.
Am. J. Pathol.
2009;175;3
Suppression of experimental autoimmune encephalomyelitis by ghrelin.
J. Immunol.
2009;183;4
Fully functional bioengineered tooth replacement as an organ replacement therapy.
Proc. Natl. Acad. Sci. U.S.A.
2009;106;32
Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer.
Cancer Gene Ther.
2009;16;8
Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.
J. Immunol.
2009;183;2
[ See timeline ] [ See all publications ]
means that Mizuno, Masayuki has 22 papers cited a least 22 times - methodology
Department of Surgery, Iwate Medical University.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.